Company profile for Longhorn Vaccines & Diagnostics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The original FDA-cleared inactivation media proven effective for High Throughput and Point of Care SARS-CoV-2, Influenza, Monkeypox, and Multiplex testing.Longhorn Vaccines and Diagnostics, LLC is a veteran-owned, family-funded company, focused on molecular tool, assay and vaccine development. With an emphasis on innovation, our goal is to improve molecular diagnostics to serve critical unmet needs in both the developed and de...
The original FDA-cleared inactivation media proven effective for High Throughput and Point of Care SARS-CoV-2, Influenza, Monkeypox, and Multiplex testing.Longhorn Vaccines and Diagnostics, LLC is a veteran-owned, family-funded company, focused on molecular tool, assay and vaccine development. With an emphasis on innovation, our goal is to improve molecular diagnostics to serve critical unmet needs in both the developed and developing world. Since 2006, we have been designing and developing products in preparation for the universal influence of a pandemic.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2 Bethesda Metro Center Suite 910 Bethesda, MD 20814
Telephone
Telephone
(301) 233-1551
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251125838043/en/Longhorn-Vaccines-Diagnostics-PrimeStore-MTM-Validated-with-New-Data-for-Large-Scale-Global-TB-Screening

BUSINESSWIRE
25 Nov 2025

https://www.businesswire.com/news/home/20251113022583/en/Longhorn-Vaccines-Diagnostics-to-Present-Data-on-Large-Scale-TB-Screening-with-PrimeStore-MTM-at-The-Union-World-Conference-on-Lung-Health-2025

BUSINESSWIRE
13 Nov 2025

https://www.businesswire.com/news/home/20250910439061/en/Longhorn-Vaccines-and-Diagnostics-to-Present-Late-Breaking-Poster-at-ESCMID-2025-on-LHNVD-303-to-Treat-and-Prevent-Antimicrobial-Resistance

BUSINESSWIRE
10 Sep 2025

https://www.businesswire.com/news/home/20250728075465/en/Longhorn-Vaccines-and-Diagnostics-Partners-with-Promega-to-Combine-Complementary-Offerings-for-Enhanced-Sample-Collection-Transport-and-Analysis

BUSINESSWIRE
28 Jul 2025

https://www.businesswire.com/news/home/20250508170068/en/Longhorn-Vaccines-and-Diagnostics-Validates-Efficacy-of-PrimeStore-Molecular-Transport-Medium-MTM-to-Inactivate-Deadly-Pathogens

BUSINESSWIRE
08 May 2025

https://www.businesswire.com/news/home/20250425223524/en/Longhorn-Vaccines-and-Diagnostics-Presents-Compelling-Data-on-LHNVD-303-Vaccine-for-Sepsis-Related-to-Bacterial-Infections-at-the-World-Vaccine-Congress

BUSINESSWIRE
25 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty